Advertisement
*
Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.

Bone Care bought for $600 million; Wisconsin Angel Network launches

Bone Care, a UW-Madison spinoff that develops a drug for kidney-disease patients, is being acquired for $600 million. The buyer? Massachusetts-based Genzyme, a multi-billion-dollar biotech. Also: the Wisconsin Angel Network gives entrepreneurs and angel investors a new way to find each other, and UW-Madison reviews desktop search engines.

Original air date: Saturday, May 7, 2005

-Add Your Comment

Name:
E-mail:

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.

WTN Media Presents